I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Steven Thompson is someone who has spent more than two decades reshaping how clinical research actually gets done. He is the Founder of NexTrial.ai, and a leading voice at the intersection of AI, trial activation, and human centred design in healthcare.

Across roles at ADM, NuBank, Takeda, and Biogen, Steven built a reputation for transforming complex, slow, legacy processes into streamlined systems that empower the people doing the work. His philosophy is simple but radical: AI shouldn’t replace humans - it should erase the maze that holds them back.

At NexTrial.ai, he’s pioneering Trial Activation & Execution Intelligence that delivers zero rejection packets, faster startup, stronger compliance and a future where coordinators, physicians, and teams can operate at their highest capability.

Steven brings clarity, courage, and a builder’s mindset to every conversation.

*A warning, that this episode discusses important but potentially difficult topics including suicide, if you are in crisis please seek professional help.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Amelia Wrighton is the Co-Founder and CEO of the charity Suicide & Co. Her commitment to suicide bereavement is rooted in her lived experience, and is a powerful thread running through her work and leadership.

Amelia lost her mum to suicide at the age of 19, a moment that reshaped her life and set her on a path of advocacy, support and systemic change.

Instead of allowing that loss to remain silent, she chose to transform it into action, co‑founding the organisation, Suicide & Co in 2020, dedicated to helping people navigate the complex, often overlooked journey of bereavement by suicide.

She has developed services that offer counselling, guidance and a sense of community for those who suddenly find themselves in a world that doesn’t always know how to talk about traumatic grief.

The charity has been transformative in supporting my family's grief journey to recovery, since losing my darling younger sister Naomi to suicide in September 2024 and for that I will be eternally grateful.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Scott Schliebner is a seasoned biopharmaceutical executive with nearly 30 years of experience spanning biotech, CROs, and nonprofit life sciences organizations.

He currently serves as CEO and Founder of Assent Biostrategies.

Throughout his career, Scott has built and led high‑impact teams across drug development, commercial strategy, and patient‑centric innovation. His leadership includes senior roles such as Chief Commercial Officer for early‑stage biopharma service organizations and Senior Vice President at TFS HealthScience, where he oversaw clinical development services and contributed to corporate strategy and acquisition due diligence.

Scott is widely recognized as a patient advocate and strategic thinker who helps biotech companies accelerate their pipelines and design development programs that meaningfully incorporate patient needs.